CN101679323A - 用于治疗杜兴氏肌营养不良症的化合物的多晶型体 - Google Patents

用于治疗杜兴氏肌营养不良症的化合物的多晶型体 Download PDF

Info

Publication number
CN101679323A
CN101679323A CN200880015864A CN200880015864A CN101679323A CN 101679323 A CN101679323 A CN 101679323A CN 200880015864 A CN200880015864 A CN 200880015864A CN 200880015864 A CN200880015864 A CN 200880015864A CN 101679323 A CN101679323 A CN 101679323A
Authority
CN
China
Prior art keywords
polymorphic forms
ethylsulfonyl
oxazole
benzo
naphthalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880015864A
Other languages
English (en)
Chinese (zh)
Inventor
亚历山大·查尔斯·韦茅斯-威尔逊
莎芭娜·艾哈迈德
马克·威廉·霍珀
凯伦·琼·埃瑟林顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Publication of CN101679323A publication Critical patent/CN101679323A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN200880015864A 2007-08-15 2008-08-14 用于治疗杜兴氏肌营养不良症的化合物的多晶型体 Pending CN101679323A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0715937.9A GB0715937D0 (en) 2007-08-15 2007-08-15 Method of treatment og duchenne muscular dystrophy
GB0715937.9 2007-08-15
PCT/EP2008/006718 WO2009021748A2 (en) 2007-08-15 2008-08-14 Polymorphs of a compound for the treatment of duchenne muscular dystrophy

Publications (1)

Publication Number Publication Date
CN101679323A true CN101679323A (zh) 2010-03-24

Family

ID=38566447

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200880015864A Pending CN101679323A (zh) 2007-08-15 2008-08-14 用于治疗杜兴氏肌营养不良症的化合物的多晶型体
CN2008800158003A Pending CN101896475A (zh) 2007-08-15 2008-08-14 用于治疗杜兴氏肌营养不良的化合物的制备

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2008800158003A Pending CN101896475A (zh) 2007-08-15 2008-08-14 用于治疗杜兴氏肌营养不良的化合物的制备

Country Status (17)

Country Link
US (2) US8138351B2 (cg-RX-API-DMAC7.html)
EP (2) EP2176246A2 (cg-RX-API-DMAC7.html)
JP (2) JP2010535830A (cg-RX-API-DMAC7.html)
KR (1) KR20100075777A (cg-RX-API-DMAC7.html)
CN (2) CN101679323A (cg-RX-API-DMAC7.html)
AR (1) AR068810A1 (cg-RX-API-DMAC7.html)
AU (2) AU2008286324A1 (cg-RX-API-DMAC7.html)
BR (2) BRPI0811548A2 (cg-RX-API-DMAC7.html)
CA (2) CA2685939A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008002391A1 (cg-RX-API-DMAC7.html)
GB (1) GB0715937D0 (cg-RX-API-DMAC7.html)
IL (1) IL201908A0 (cg-RX-API-DMAC7.html)
MX (2) MX2009011916A (cg-RX-API-DMAC7.html)
PE (1) PE20090604A1 (cg-RX-API-DMAC7.html)
RU (1) RU2009141831A (cg-RX-API-DMAC7.html)
TW (1) TW200911767A (cg-RX-API-DMAC7.html)
WO (2) WO2009021749A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109803641A (zh) * 2016-03-30 2019-05-24 萨米特(牛津)有限公司 用于治疗杜兴氏肌肉营养不良症的组合物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0707719A2 (pt) * 2006-02-10 2011-05-10 Summit Corp Plc uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo
GB201208178D0 (en) 2012-05-10 2012-06-20 Summit Corp Plc Pharmaceutical composition for the treatment of duchenne muscular dystrophy
GB201412010D0 (en) 2014-07-04 2014-08-20 Summit Corp Plc Treatment of hypertransaminasemia
WO2017175842A1 (ja) * 2016-04-07 2017-10-12 国立大学法人京都大学 スプライシングの改変に関する化合物及び医薬組成物
KR102019048B1 (ko) 2017-02-06 2019-09-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 근육긴장저하 치료제 스크리닝 방법
KR101886788B1 (ko) 2017-02-07 2018-08-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 뒤시엔느 골격근 위축증 치료제 스크리닝 방법
WO2018236879A1 (en) 2017-06-19 2018-12-27 University Of Maryland, Baltimore INHIBITORS OF MICROTUBULAR POLYMERIZATION PRODRUGS AND METHODS OF USE

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993659A (en) * 1971-08-10 1976-11-23 Ciba-Geigy Corporation Bis-benzoxazolyl-naphthalenes as optical brighteners
CH617809GA3 (cg-RX-API-DMAC7.html) * 1975-10-10 1980-06-30
US4110246A (en) * 1976-05-13 1978-08-29 Hoechst Aktiengesellschaft Mixture of benzoxazole derivatives
DE3027479A1 (de) * 1980-07-19 1982-03-04 Hoechst Ag, 6000 Frankfurt Mischungen von optischen aufhellern und deren verwendung
JPS615071A (ja) * 1984-06-15 1986-01-10 Fuji Photo Film Co Ltd ベンゾオキサゾ−ル誘導体
DE3617451A1 (de) * 1986-05-23 1987-11-26 Hoechst Ag Sulfonat- oder sulfonamidgruppen-haltige bis-benzoxazolylnaphthaline, verfahren zu deren herstellung und deren verwendung
DE3819051A1 (de) * 1988-06-04 1989-12-07 Agfa Gevaert Ag Farbfotografisches aufzeichnungsmaterial
ES2092080T3 (es) * 1991-08-08 1996-11-16 Ciba Geigy Ag Colorantes, procedimiento para su obtencion y su utilizacion.
ES2157268T5 (es) * 1994-02-24 2004-12-01 SYMRISE GMBH & CO KG Preparados cosmeticos y dermatologicos que contienen acidos fenilen-1,4-bisbencimidazolsulfonicos.
US6004719A (en) * 1994-04-25 1999-12-21 Polaroid Corporation Imaging medium and process for producing an image
EP0767809B1 (en) * 1994-06-30 2004-01-21 Minnesota Mining And Manufacturing Company Cure-indicating molding and coating composition
US5596025A (en) * 1994-06-30 1997-01-21 Minnesota Mining And Manufacturing Company Dental impression material with cure-indicating dye
US5567843A (en) * 1995-03-20 1996-10-22 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid)azoles and 2-aminoaryl aminobenz(ox, thi, imid)azoles
US6222044B1 (en) * 1995-03-20 2001-04-24 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid) azoles and 2-aminoaryl aminobenz (ox, thi, imid) azoles
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5645948A (en) * 1996-08-20 1997-07-08 Eastman Kodak Company Blue organic electroluminescent devices
US5914213A (en) * 1996-11-27 1999-06-22 Polaroid Corporation Process and composition for generation of acid
US6110638A (en) * 1996-11-27 2000-08-29 Polaroid Corporation Process and composition for generation of acid
US6177572B1 (en) * 1997-08-20 2001-01-23 Sepracor, Inc. Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
US6312822B1 (en) * 1998-05-28 2001-11-06 Eastman Chem Co Dispersion aids for optical brighteners in polyolefins
GB9815880D0 (en) * 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6436558B1 (en) * 1998-08-07 2002-08-20 Fuji Photo Film Co., Ltd. Organic electroluminescence element
FR2789582B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
FR2789581B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de benzotriazole, un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
EP1177179A1 (de) * 1999-05-07 2002-02-06 Basf Aktiengesellschaft Benzoheterocyclylcyclohexenone und ihre verwendung als herbizide
WO2000068228A1 (de) * 1999-05-07 2000-11-16 Basf Aktiengesellschaft 4-(3',4'-heterocyclylbenzoyl) pyrazole als herbizide
FR2794645B1 (fr) * 1999-06-08 2001-08-10 Oreal Compositions photoprotectrices contenant un compose hydrocarbone bis-hydroxyphenylbenzotriazole et un compose a groupements benzoazolyle ou benzodiazolyle
AU7320100A (en) * 1999-09-24 2001-04-24 Ono Pharmaceutical Co. Ltd. Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
US6565987B2 (en) * 1999-11-12 2003-05-20 Eastman Chemical Company Non-exuding optically brightened polyolefin blends
US6716413B1 (en) * 2000-10-16 2004-04-06 Mallinckrodt, Inc. Indole compounds as tissue-specific exogenous optical agents
EP1881050B1 (en) * 2000-11-30 2013-01-09 Canon Kabushiki Kaisha Luminescence device and display apparatus
US20050113283A1 (en) * 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
US20050261298A1 (en) * 2002-01-18 2005-11-24 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
EP1482931B1 (en) * 2002-03-05 2011-10-19 TransTech Pharma, Inc. Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
JPWO2004035522A1 (ja) * 2002-08-30 2006-02-16 株式会社 ビーエフ研究所 プリオン蛋白蓄積性疾患の診断プローブおよび治療薬ならびにプリオン蛋白の染色剤
US20040248957A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Heterocyclic compounds and uses thereof
CN1805743A (zh) * 2003-05-20 2006-07-19 特兰斯泰克制药公司 用作逆转淀粉样变性及其他与之相关疾病的rage拮抗剂
SG146624A1 (en) * 2003-09-11 2008-10-30 Kemia Inc Cytokine inhibitors
WO2005029187A1 (en) * 2003-09-22 2005-03-31 Agfa-Gevaert Photopolymerizable composition.
US7097888B2 (en) * 2003-12-15 2006-08-29 Eastman Kodak Company Aligned liquid crystal layer containing azolium salts and process for increasing the tilt
US7592373B2 (en) * 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
AU2005211255A1 (en) * 2004-02-06 2005-08-18 Insight Biopharmaceuticals Ltd Heparanase inhibitors and uses thereof
MY144903A (en) * 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists
WO2006019270A1 (en) * 2004-08-19 2006-02-23 Lg Chem. Ltd. Organic light-emitting device comprising buffer layer and method for fabricating the same
US7723340B2 (en) * 2005-01-13 2010-05-25 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
US20060223849A1 (en) * 2005-03-14 2006-10-05 Mjalli Adnan M Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
JP2007086165A (ja) * 2005-09-20 2007-04-05 Fujifilm Corp 感光性組成物、これを用いた平版印刷版原版及び画像記録方法
CA2630806C (en) * 2005-12-02 2015-01-06 Sachem, Inc. Anion-exchange displacement chromatography process and anionic organic compounds for use as displacer compounds in anion-exchange displacement chromatography process
KR101213485B1 (ko) * 2006-01-27 2012-12-18 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
KR101213486B1 (ko) * 2006-02-02 2012-12-20 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
BRPI0707719A2 (pt) * 2006-02-10 2011-05-10 Summit Corp Plc uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo
KR101325062B1 (ko) * 2006-05-19 2013-11-05 삼성디스플레이 주식회사 발광 이종 핵 구리-이리듐 착체 및 이를 이용한 유기 전계발광 소자

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109803641A (zh) * 2016-03-30 2019-05-24 萨米特(牛津)有限公司 用于治疗杜兴氏肌肉营养不良症的组合物

Also Published As

Publication number Publication date
EP2188270A2 (en) 2010-05-26
GB0715937D0 (en) 2007-09-26
EP2176246A2 (en) 2010-04-21
BRPI0811315A2 (pt) 2015-01-27
WO2009021748A3 (en) 2009-04-02
RU2009141831A (ru) 2011-05-20
MX2009011967A (es) 2009-11-19
IL201908A0 (en) 2010-06-16
AU2008286325A1 (en) 2009-02-19
MX2009011916A (es) 2009-11-18
JP2010535830A (ja) 2010-11-25
US20090048314A1 (en) 2009-02-19
CN101896475A (zh) 2010-11-24
TW200911767A (en) 2009-03-16
AU2008286324A1 (en) 2009-02-19
JP2010535829A (ja) 2010-11-25
CA2685590A1 (en) 2009-02-19
US8138351B2 (en) 2012-03-20
AR068810A1 (es) 2009-12-09
US20100267961A1 (en) 2010-10-21
CA2685939A1 (en) 2009-02-19
PE20090604A1 (es) 2009-05-16
WO2009021749A8 (en) 2009-09-11
WO2009021748A2 (en) 2009-02-19
WO2009021749A3 (en) 2009-04-02
CL2008002391A1 (es) 2009-05-22
KR20100075777A (ko) 2010-07-05
WO2009021749A2 (en) 2009-02-19
BRPI0811548A2 (pt) 2014-11-18

Similar Documents

Publication Publication Date Title
EP3872077B1 (en) Heterocyclic amide for inhibiting rip1 kinase and uses thereof
US20090048314A1 (en) Treatment of duchenne muscular dystrophy
US12065447B2 (en) Heterocyclic amide for inhibiting RIP1 kinase and uses thereof
KR102792113B1 (ko) Stat3 억제제
ES2558087T3 (es) Procesos para la preparación de moduladores del receptor S1P1 y formas cristalinas de los mismos
US20120149741A1 (en) Treatment of duchenne muscular dystrophy
KR20110058849A (ko) 자가면역 및 염증성 장애의 치료에 유용한, s1p1 수용체 효능제로서의 치환된 트리시클릭 산 유도체
JP7681059B2 (ja) ヤーヌスキナーゼ(jak)ファミリー阻害剤及びその調製と使用
WO2019204427A1 (en) Methods for measuring and stabilizing stat3 inhibitors
US20240182429A1 (en) Heterocyclic compound as tyk2 pseudokinase domain inhibitor, synthetic method, and use
BR112013007073A2 (pt) derivados do cromeno; composição farmacêutica; utilização de um composto da fórmula i e processo de preparação de um composto da fórmula i
EP3542796B1 (en) Compound having anti-cancer effect, and preparation method therefor and use thereof
KR20210005021A (ko) 화합물의 결정성 형태
JP2024504785A (ja) ピペラジニル-チアゾール誘導体の結晶形
EP4116300A1 (en) Crystal of tricyclic compound acting on crbn protein and preparation method therefor
KR100874209B1 (ko) 3,10-다이하이드로-1H-[1,4]다이아제피노[5,6-b]인돌-2-온 유도체 및 약학적으로 허용 가능한 염, 그의 제조방법및 그의 용도
JP6993721B2 (ja) 抗がん作用を有する化合物およびその製造方法ならびにその応用
TW202100513A (zh) 氘原子取代的吲哚甲酰胺類衍生物的晶型及其製備方法
WO2025229046A1 (en) Substituted hydroquinolines for the treatment of glioblastoma multiforme
TW202608881A (zh) 咪唑稠環類化合物、藥物組成物及其製備方法和用途
WO2026050911A1 (zh) 一种TR-β选择性激动剂的晶型、制备方法和应用
CN120500337A (zh) 半乳糖凝集素-3抑制剂及其对阿尔茨海默病的治疗作用
EP3271356B1 (en) Selective bace1 inhibitors
JP2025538576A (ja) キノリンアミン系化合物の結晶型及びその調製方法
CN104000817A (zh) 制备一类含1,3,4-噁二唑啉的吡唑衍生物治、防肿瘤的药物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100324